Syringaresinol-4-O-β-d-glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes

• Main Authors: Shuai Wang (Author), Chongming Wu (Author), Xin Li (Author), Yue Zhou (Author), Quanyang Zhang (Author), Fuchao Ma (Author), Jianhe Wei (Author), Xiaopo Zhang (Author), Peng Guo (Author)
• Format: Book
• Published: Elsevier, 2017-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Syringaresinol-4-O-β-d-glucoside (SSG), a furofuran-type lignan, was found to modulate lipid and glucose metabolism through an activity screen of lipid accumulation and glucose consumption, and was therefore considered as a promising candidate for the prevention and treatment of metabolic disorder,...